magbo system

Globus Medical (NYSE:GMED) reported second-quarter results that beat the overall consensus on Wall Street. The Audubon, Pennsylvania-based musculoskeletal device company reported profits of $54.6 million, or 53¢ per share, on sales of $263.6 million for the three months ended June 30, for a bottom-line gain of 31.4% on sales growth of 5.03% compared with Q2…